MarketWatch Vosaroxin is a first-in-class anti-cancer quinolone derivative (AQD), a class of compounds that has not been used previously for the treatment of cancer. Vosaroxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, ... and more »
NASDAQ Vosaroxin is an anti-cancer quinolone derivative, a class of compounds that has not been used previously for the treatment of cancer. The Phase I/II, open-label...
